BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15983959)

  • 21. Low serum phosphate as an independent predictor of increased infection-related mortality in dialysis patients: A prospective multicenter cohort study.
    Lee JE; Lim JH; Jang HM; Kim YS; Kang SW; Yang CW; Kim NH; Kwon E; Kim HJ; Park JM; Jung HY; Choi JY; Park SH; Kim CD; Cho JH; Kim YL;
    PLoS One; 2017; 12(10):e0185853. PubMed ID: 28973026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensified treatment of hyperphosphatemia associated with reduction in parathyroid hormone in patients on maintenance hemodialysis.
    Chen L; He JX; Chen YY; Ling YS; Lin CH; Guan TJ
    Ren Fail; 2018 Nov; 40(1):15-21. PubMed ID: 29295646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status.
    Lopes AA; Tong L; Thumma J; Li Y; Fuller DS; Morgenstern H; Bommer J; Kerr PG; Tentori F; Akiba T; Gillespie BW; Robinson BM; Port FK; Pisoni RL
    Am J Kidney Dis; 2012 Jul; 60(1):90-101. PubMed ID: 22385781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
    Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
    Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?
    Wang AY; Woo J; Sea MM; Law MC; Lui SF; Li PK
    Am J Kidney Dis; 2004 Apr; 43(4):712-20. PubMed ID: 15042549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower serum potassium associated with increased mortality in dialysis patients: A nationwide prospective observational cohort study in Korea.
    Lee S; Kang E; Yoo KD; Choi Y; Kim DK; Joo KW; Yang SH; Kim YL; Kang SW; Yang CW; Kim NH; Kim YS; Lee H
    PLoS One; 2017; 12(3):e0171842. PubMed ID: 28264031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.
    Rhee CM; Nguyen DV; Moradi H; Brunelli SM; Dukkipati R; Jing J; Nakata T; Kovesdy CP; Brent GA; Kalantar-Zadeh K
    Am J Kidney Dis; 2015 Aug; 66(2):313-21. PubMed ID: 25824125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival of Patients on Hemodialysis and Predictors of Mortality: a Single-Centre Analysis of Time-Dependent Factors.
    Ossareh S; Farrokhi F; Zebarjadi M
    Iran J Kidney Dis; 2016 Nov; 10(6):369-380. PubMed ID: 27903996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes.
    Stevens LA; Djurdjev O; Cardew S; Cameron EC; Levin A
    J Am Soc Nephrol; 2004 Mar; 15(3):770-9. PubMed ID: 14978180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic function and survival in hemodialysis patients.
    Kimmel PL; Phillips TM; Simmens SJ; Peterson RA; Weihs KL; Alleyne S; Cruz I; Yanovski JA; Veis JH
    Kidney Int; 1998 Jul; 54(1):236-44. PubMed ID: 9648084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients.
    Phelan PJ; O'Kelly P; Walshe JJ; Conlon PJ
    Ren Fail; 2008; 30(4):423-9. PubMed ID: 18569917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients.
    Hsu SP; Pai MF; Peng YS; Chiang CK; Ho TI; Hung KY
    Nephrol Dial Transplant; 2004 Feb; 19(2):457-62. PubMed ID: 14736974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemoglobin predicts long-term survival in dialysis patients: a 15-year single-center longitudinal study and a correlation trend between prealbumin and hemoglobin.
    Avram MM; Blaustein D; Fein PA; Goel N; Chattopadhyay J; Mittman N
    Kidney Int Suppl; 2003 Nov; (87):S6-11. PubMed ID: 14531767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes Mellitus and Younger Age Are Risk Factors for Hyperphosphatemia in Peritoneal Dialysis Patients.
    Imtiaz R; Hawken S; McCormick BB; Leung S; Hiremath S; Zimmerman DL
    Nutrients; 2017 Feb; 9(2):. PubMed ID: 28218647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access.
    Lacson E; Wang W; Hakim RM; Teng M; Lazarus JM
    Am J Kidney Dis; 2009 Jan; 53(1):79-90. PubMed ID: 18930570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum phosphate and social deprivation independently predict all-cause mortality in chronic kidney disease.
    Solbu MD; Thomson PC; Macpherson S; Findlay MD; Stevens KK; Patel RK; Padmanabhan S; Jardine AG; Mark PB
    BMC Nephrol; 2015 Dec; 16():194. PubMed ID: 26627078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating phosphate removal in haemodialysis: an additional tool to quantify dialysis dose.
    Gutzwiller JP; Schneditz D; Huber AR; Schindler C; Gutzwiller F; Zehnder CE
    Nephrol Dial Transplant; 2002 Jun; 17(6):1037-44. PubMed ID: 12032194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to treatment and hospitalization risk in hemodialysis patients.
    Vaiciuniene R; Kuzminskis V; Ziginskiene E; Skarupskiene I; Bumblyte IA
    J Nephrol; 2012; 25(5):672-8. PubMed ID: 21983989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.